Literature DB >> 22010805

Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.

Hudson Reddon1, Evan Wood, Mark Tyndall, Calvin Lai, Robert Hogg, Julio Montaner, Thomas Kerr.   

Abstract

The objective of this study was to examine supervised injecting facility (SIF) use among a cohort of 395 HIV-positive injection drug users (IDUs) in Vancouver, Canada. The correlates of SIF use were identified using generalized estimating equation analyses. In multivariate analyses, frequent SIF use was associated with homelessness (adjusted odds ratio [AOR] = 1.90), daily heroin injection (AOR = 1.56), and daily cocaine injection (AOR = 1.59). The reasons given for not using the SIF included a preference for injecting at home and already having a safe place to inject. The SIF services most commonly used were needle exchange and nursing services. The SIF appears to have attracted a high-risk subpopulation of HIV-positive IDUs; this coverage perhaps could be extended with the addition of HIV-specific services such as disease monitoring and the provision of antiretroviral therapy.

Entities:  

Mesh:

Year:  2011        PMID: 22010805      PMCID: PMC3799861          DOI: 10.1521/aeap.2011.23.5.412

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  44 in total

1.  Incarceration and risk for HIV infection among injection drug users in Bangkok.

Authors:  Kachit Choopanya; Don C Des Jarlais; Suphak Vanichseni; Dwip Kitayaporn; Philip A Mock; Suwanee Raktham; Krit Hireanras; William L Heyward; Sathit Sujarita; Timothy D Mastro
Journal:  J Acquir Immune Defic Syndr       Date:  2002-01-01       Impact factor: 3.731

Review 2.  Structural interventions to reduce HIV transmission among injecting drug users.

Authors:  D C Des Jarlais
Journal:  AIDS       Date:  2000-06       Impact factor: 4.177

Review 3.  Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration.

Authors:  Sandro Galea; David Vlahov
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

4.  High rates of primary care and emergency department use among injection drug users in Vancouver.

Authors:  T Kerr; E Wood; E Grafstein; T Ishida; K Shannon; C Lai; J Montaner; M W Tyndall
Journal:  J Public Health (Oxf)       Date:  2004-11-25       Impact factor: 2.341

5.  Changes in injecting practices associated with the use of a medically supervised safer injection facility.

Authors:  Jo-Anne Stoltz; Evan Wood; Will Small; Kathy Li; Mark Tyndall; Julio Montaner; Thomas Kerr
Journal:  J Public Health (Oxf)       Date:  2007-01-17       Impact factor: 2.341

6.  Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.

Authors:  D M Patrick; M W Tyndall; P G Cornelisse; K Li; C H Sherlock; M L Rekart; S A Strathdee; S L Currie; M T Schechter; M V O'Shaughnessy
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

7.  HIV incidence among injection drug users in Baltimore, Maryland (1988-2004).

Authors:  Shruti H Mehta; Noya Galai; Jacquie Astemborski; David D Celentano; Steffanie A Strathdee; David Vlahov; Kenrad E Nelson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-11-01       Impact factor: 3.731

8.  Survey of drug consumption rooms: service delivery and perceived public health and amenity impact.

Authors:  Jo Kimber; Kate Dolan; Alex Wodak
Journal:  Drug Alcohol Rev       Date:  2005-01

9.  A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.

Authors:  Thomas Kerr; Will Small; David Moore; Evan Wood
Journal:  Int J Drug Policy       Date:  2007-01-16

10.  Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facility.

Authors:  M-J S Milloy; Thomas Kerr; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  PLoS One       Date:  2008-10-07       Impact factor: 3.240

View more
  10 in total

Review 1.  Novel interventions to prevent HIV and HCV among persons who inject drugs.

Authors:  Phillip O Coffin; Christopher Rowe; Glenn-Milo Santos
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

2.  Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review.

Authors:  Katrina Bouzanis; Siddharth Joshi; Cynthia Lokker; Sureka Pavalagantharajah; Yun Qiu; Hargun Sidhu; Lawrence Mbuagbaw; Majdi Qutob; Alia Henedi; Mitchell A H Levine; Robin Lennox; Jean-Eric Tarride; Dale Kalina; Elizabeth Alvarez
Journal:  BMJ Open       Date:  2021-09-23       Impact factor: 3.006

3.  Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: A longitudinal analysis.

Authors:  Sarah Ickowicz; Evan Wood; Huiru Dong; Paul Nguyen; Will Small; Thomas Kerr; Julio S G Montaner; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2017-08-10       Impact factor: 4.492

4.  Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada.

Authors:  Mary Clare Kennedy; David C Klassen; Huiru Dong; M-J S Milloy; Kanna Hayashi; Thomas H Kerr
Journal:  Am J Prev Med       Date:  2019-08-01       Impact factor: 5.043

5.  Assisted injection within supervised injection services: Uptake and client characteristics among people who require help injecting in a Canadian setting.

Authors:  Mary Clare Kennedy; M-J Milloy; Kanna Hayashi; Elizabeth Holliday; Evan Wood; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2020-10-08

6.  Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis.

Authors:  Javier A Cepeda; Peter Vickerman; Julie Bruneau; Geng Zang; Annick Borquez; Michael Farrell; Louisa Degenhardt; Natasha K Martin
Journal:  Drug Alcohol Depend       Date:  2020-06-24       Impact factor: 4.492

Review 7.  Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis.

Authors:  Elisa Mountain; Sharmistha Mishra; Peter Vickerman; Michael Pickles; Charles Gilks; Marie-Claude Boily
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

8.  Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol.

Authors:  Marc Auriacombe; Perrine Roux; Laurence Lalanne; Marie Jauffret-Roustide; Laélia Briand Madrid; Sébastien Kirchherr; Charlotte Kervran; Carole Chauvin; Marie Gutowski; Cécile Denis; Maria Patrizia Carrieri
Journal:  BMJ Open       Date:  2019-02-21       Impact factor: 2.692

Review 9.  Assessing Drug Consumption Rooms and Longer Term (5 Year) Impacts on Community and Clients.

Authors:  Vincent Tran; Sharon E Reid; Amanda Roxburgh; Carolyn A Day
Journal:  Risk Manag Healthc Policy       Date:  2021-11-15

10.  Risk environments facing potential users of a supervised injection site in Ottawa, Canada.

Authors:  Ashley Shaw; Lisa Lazarus; Tyler Pantalone; Sean LeBlanc; Dolly Lin; Daina Stanley; Caleb Chepesiuk; Sheetal Patel; Mark Tyndall
Journal:  Harm Reduct J       Date:  2015-10-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.